○野上 尚之1, Enriqueta Felip2, Byoung Chul Cho3, Vanesa Gutierrez4, Adlinda Alip5, Benjamin Besse6, Shun Lu7, Alexander I. Spira8, Nicolas Girard9, Raffaele Califano10, Shirish M Gadgeel11, James Chih-Hsin Yang12, Koichi Azuma13, Joshua C Curtin14, Jiarui Zhang14, Anesh Panchal15, Mariah Ennis14, Seema Sethi14, Joshua M. Bauml14, Se-Hoon Lee16 (1.愛媛大学大学院医学系研究科地域胸部疾患治療学, 2.Universitat Autonoma de Barcelona, Barcelona, Spain, 3.Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea, 4.Hospital Regional Universitario de Malaga y Virgen de la Victoria, IBIMA, Malaga, Spain, 5.University of Malaya, Kuala Lumpur, Malaysia, 6.Paris-Saclay University, Gustave Roussy, Villejuif, France, 7.Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China, 8.Virginia Cancer Specialists, Fairfax, VA, USA, 9.Universite de Versailles Saint-Quentin-en-Yvelines, Versailles, France, 10.The University of Manchester, Manchester, UK, 11.Henry Ford Cancer Institute, Detroit, MI, USA, 12.National Taiwan University Hospital, Taipei, Taiwan, 13.Kurume University School of Medicine, Kurume, Japan, 14.Janssen Research & Development, Spring House, PA, USA, 15.Janssen Research & Development, High Wycombe, UK, 16.Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea)
セッション情報
ワークショップ
ワークショップ9 EGFR遺伝子変異陽性肺癌に対する治療戦略
2024年11月1日(金) 08:30 〜 10:00 第3会場 (パシフィコ横浜ノース 3階 G301+G302)
座長:倉田 宝保(関西医科大学呼吸器腫瘍内科学講座), 猶木 克彦(北里大学医学部呼吸器内科学)
○Takashi Seto1, Makoto Nishio2, Martin Reck3, Edward B. Garon4, Kazuto Nishio5, Kazuo Kasahara6, Kazumi Nishino7, Miyako Satouchi8, Kiyotaka Yoh9, Hidetoshi Hayashi10, Kazuko Sakai5, Sotaro Enatsu11, Bente Frimodt-Moller12, Tomoko Matsui11, Sunoj Chacko Varughese13, Michelle Carlsen14, Carla M. Visseren-Grul15, Kazuhiko Nakagawa10 (1.Department of Thoracic Oncology, NHO Kyushu Cancer Center, Fukuoka, Japan, 2.Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan, 3.Department of Thoracic Oncology, Airway Research Center North, German Center for Lung Research, LungClinic, Grosshansdorf, Germany, 4.David Geffen School of Medicine at UCLA/TRIO-US Network, Los Angeles, USA, 5.Department of Genome Biology, Kindai University Faculty of Medicine, Osaka, Japan, 6.Department of Pulmonary Medicine and Oncology, Nippon Medical School Hospital, Tokyo, Japan, 7.Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan, 8.Department of Thoracic Oncology, Hyogo Cancer Center, Hyogo, Japan, 9.Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan, 10.Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan, 11.Eli Lilly Japan K.K., Kobe, Japan, 12.Eli Lilly Denmark A/S, Copenhagen, Denmark, 13.Statistics, Eli Lilly Services India Pvt. Ltd., Bengaluru, India, 14.Eli Lilly and Company, Indianapolis, USA, 15.Eli Lilly Netherlands, Utrecht, The Netherlands)
○岩間 映二1, 坂井 和子2, 神田 慎太郎3, 山本 信之4, 西尾 和人2, 大江 裕一郎5, 岡本 勇1 (1.九州大学呼吸器内科, 2.近畿大学医学部, 3.信州大学医学部付属病院, 4.和歌山県立医科大学, 5.国立がん研究センター中央病院)
○大菅 光雄1, 田宮 朗裕2, 原田 大二郎3, 水守 康之4, 伊佐 俊一2, 谷口 善彦2, 中村 慧一5, 篠原 勉6, 箭内 英俊7, 中富 克己8, 沖 昌英9, 森 雅秀10, 桑子 智人11, 山崎 宏司12, 田村 厚久13, 安藤 昌彦14, 洪 泰浩1 (1.和歌山県立医科大学, 2.NHO近畿中央呼吸器センター, 3.NHO四国がんセンター, 4.NHO姫路医療センター, 5.NHO旭川医療センター, 6.NHO高知病院, 7.NHO水戸医療センター, 8.NHO嬉野医療センター, 9.NHO名古屋医療センター, 10.NHO大阪刀根山医療センター, 11.NHO渋川医療センター, 12.NHO九州医療センター, 13.NHO東京病院, 14.名古屋大学医学部附属病院)
○小林 信明1,2, 松本 大海3, 村岡 傑1,2, 染川 弘平1,2, 金子 彩美1,2, 久保 創介1,2, 金子 猛1,2 (1.横浜市立大学大学院医学研究科呼吸器病学, 2.横浜市立大学附属病院呼吸器内科, 3.理化学研究所革新知能統合研究センターがん探索医療研究チーム)
○Satoshi Oizumi1, Natalia Valdiviezo2, Isamu Okamoto3, Brett G. M. Hughes4, Samreen Ahmed5, Lin Wu6, Jie Hu7, Renzo Alvarez8, Ki Hyeong Lee9, Xuan Dung Pham10, Rohan Bhise11, Myung-Ju Ahn12, Glaucio Bertollo13, Yuichi Tambo14, Rubi Li15, Alexander Todd16, Dakshayini Kulkarni16, Neha P. Amin17, David Planchard18, Pasi A. Jänne19, Kunihiko Kobayashi20 (1.Hokkaido Cancer Center, Sapporo, Japan, 2.Instituto Nacional de Enfermedades Neoplasicas, Surquillo, Peru, 3.Kyushu University, Fukuoka, Japan, 4.The Prince Charles Hospital, and University of Queensland, Brisbane, Australia, 5.University Hospitals of Leicester NHS Trust, Leicester, UK, 6.Hunan Province Tumor Hospital, Changsha, China, 7.Zhongshan Hospital Affiliated to Fudan University, Shanghai, China, 8.Centro Medico Monte Carmelo, Calle Francisco, Arequipa, Peru, 9.Chungbuk National University Hospital, Cheongju, Republic of Korea, 10.HCMC Oncology Hospital, Binh Thanh District, Ho Chi Minh City, Vietnam, 11.J N Medical College and KLES Dr. Prabhakar Kore Hospital and MRC, Nehru Nagar, Belagavi, India, 12.Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea, 13.AFECC/Hospital Santa Rita, Vitória, Brazil, 14.Kanazawa University Hospital, Kanazawa, Japan, 15.St. Luke's Medical Center, Quezon City, Philippines, 16.AstraZeneca, Cambridge, UK, 17.AstraZeneca, Gaithersburg, MD, USA, 18.Université Paris-Saclay, Paris, France, 19.Dana-Farber Cancer Institute, Boston, MA, USA, 20.Saitama Medical University, Saitama, Japan)